Search results
Eli Lilly and Co (LLY) Surpasses Q1 Earnings Estimates and Raises Full-Year Guidance
GuruFocus.com via Yahoo Finance· 3 days agoKey Product Performance: Mounjaro and Zepbound led revenue growth, with Mounjaro alone generating...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
San Francisco Chronicle· 2 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
...Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and...
Benzinga· 2 days agoTuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over...
Novo Nordisk expects 27% sales surge this year but faces price pressure amid Eli Lilly competition
Fortune· 18 hours agoRamping up production is a key element of Novo’s strategy as it battles Eli Lilly & Co. for supremacy in the weight-loss market. Demand for the obesity ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters via Yahoo Finance· 3 days ago(Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug...
Eli Lilly lifts 2024 sales view by $2 billion on weight-loss drug demand By Reuters
Investing.com· 3 days agoMost doses of Mounjaro and Zepbound are expected to be available in limited amounts through the...
Brokerages Set Eli Lilly and Company (NYSE:LLY) Target Price at $728.05
ETF DAILY NEWS· 4 days agoShares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nineteen ratings firms that ...
Eli Lilly Stock Jumps After It Signals Rise in Obesity and Diabetes Drugs Production
The Wall Street Journal· 3 days agoSupply constraints for a popular class of diabetes and obesity drugs limited **Eli Lilly**’s...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion By Reuters
Investing.com· 3 days agoLilly said it expects significant production increases in the second half of the year for its...
Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast
Benzinga via AOL· 3 days agoTuesday, Eli Lilly And Co (NYSE:LLY) reported first-quarter revenue of $8.77 billion, up 26% year...